ロード中...
Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies
It has been nearly two decades since RNA-interference (RNAi) was first reported. While there are no approved clinical uses, several promising phase II and III clinical trials suggest the great promise of RNAi therapeutics. One challenge for RNAi therapies is the controlled localization and sustained...
保存先:
| 出版年: | Adv Healthc Mater |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5226889/ https://ncbi.nlm.nih.gov/pubmed/27976524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adhm.201601041 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|